Background. Long‐term effectiveness of a dapsone compliance program was assessed in patients with leprosy. Methods. The monitoring program consists of urine dap‐sone/creatinine ratio determination at each visit with subsequent patient feedback and education. Eighty‐eight patients receiving dapsone and seen in a leprosy clinic from 1985–1990 were included. Results. The proportion of patients compliant with dapsone during a given year ranged from 70.0% (1987) to 94.4% (1989). Overall compliance for the 6‐year period was 81.6%. This level of compliance was significantly different (P < 0.05) than the baseline compliance in the leprosy clinic of 46.7%. Conclusions. Compliance monitoring, combined with active patient involvement, was effective in sustaining high compliance over a 6‐year period.
|Original language||English (US)|
|Number of pages||4|
|Journal||International Journal of Dermatology|
|State||Published - Mar 1993|
ASJC Scopus subject areas